CN113730089A - Amblyopia treatment device capable of intelligently guiding visual stimulation - Google Patents

Amblyopia treatment device capable of intelligently guiding visual stimulation Download PDF

Info

Publication number
CN113730089A
CN113730089A CN202111147800.2A CN202111147800A CN113730089A CN 113730089 A CN113730089 A CN 113730089A CN 202111147800 A CN202111147800 A CN 202111147800A CN 113730089 A CN113730089 A CN 113730089A
Authority
CN
China
Prior art keywords
lens
membrane
film
adjusting
amblyopia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111147800.2A
Other languages
Chinese (zh)
Other versions
CN113730089B (en
Inventor
樊云葳
李宁东
李莉
吴倩
曹文红
王媛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Childrens Hospital
Original Assignee
Beijing Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Childrens Hospital filed Critical Beijing Childrens Hospital
Priority to CN202111147800.2A priority Critical patent/CN113730089B/en
Publication of CN113730089A publication Critical patent/CN113730089A/en
Application granted granted Critical
Publication of CN113730089B publication Critical patent/CN113730089B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H5/00Exercisers for the eyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/02Head
    • A61H2205/022Face
    • A61H2205/024Eyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Rehabilitation Tools (AREA)

Abstract

The invention provides an amblyopia treatment device for intelligently guiding visual stimulation, which comprises: the first dimming film is used for adjusting the light transmitting intensity of the first lens under the condition of electrifying; the first bending membrane is used for adjusting the diopter of the second lens under the condition of electrifying; first control module, the setting is on the glasses with first membrane homonymy of adjusting luminance and the first membrane of adjusting luminance is connected to the electricity, and first control module includes: a first power supply and a first control circuit board; the second control module sets up on the glasses with first flexible membrane homonymy and the first flexible membrane of electricity connection, and second control module includes: a second power supply and a second control circuit board. The invention realizes the functions of adjusting the refractive degree of the lens and the intensity of light, guides the brain to adjust ciliary muscles and other related muscles, adjusts the refractive effect of crystalline lens, gradually improves the consciousness of the brain to improve abnormal vision and treats amblyopia.

Description

Amblyopia treatment device capable of intelligently guiding visual stimulation
Technical Field
The invention relates to the field of medical instruments, in particular to an amblyopia treatment device capable of intelligently guiding visual stimulation.
Background
Amblyopia is caused by abnormal visual experiences such as monocular strabismus, ametropia, high ametropia, form deprivation and the like in the visual development period, the optimal correction vision of a single eye or two eyes is lower than that of a child with a normal age, and no organic lesions are caused in eye examination. Lower limit of normal value of vision for children of different ages: the lower limit of the normal vision of children aged 3-5 years is 0.5, and the lower limit of the normal vision of children aged 6 years and above is 0.7. Amblyopia is an eye disease which seriously harms the visual function of children, and if the eye disease is not treated in time, the amblyopia can be aggravated and even be blind.
The ametropia and ametropia weak are the highest in the prevalence rate of amblyopia. Due to different vision of two eyes, different imaging sizes and definitions of retinas of the two eyes and large and fuzzy imaging of yellow spots of one eye with higher diopter, fusion reflex stimulation of the two eyes is insufficient, so that normal development of visual function is hindered, the visual deterioration of one eye or two eyes is caused, and various sensory functions are lost. The vision deterioration is only a primary expression, and the advanced expressions comprise impaired spatial localization, reduced contrast sensitivity, low and constant stereoscopic vision, a spatial crowding phenomenon and the like.
The degree of amblyopia is not only related to the degree of the refractive error, but also to the nature of the fixation. The amblyopia imaging is schematically shown in fig. 1 and fig. 2, fig. 1 shows the imaging effect of a normal eye, the image of an object is located on the macula lutea of the fovea, and the imaging is clear. While amblyopic eye imaging is complex, for example: the imaging may fall in front of the macula, as shown in fig. 2, similar to myopia; also behind the macula, similar to hyperopia; the imaging may also fall on the macula, but is affected by the visual system and does not respond positively in the brain. The first two conditions are affected by the refractive power of the lens, like the macula which does not fall on the fovea, superficially this is similar to the imaging phenomena of myopia, hyperopia, but the pathology is completely different.
The lens of the myopia and hyperopia eyes are deformed, the muscle adjustment can not make the image fall on the macula lutea, and the condition can be adjusted to the image position by wearing the glasses. While the lens of the amblyopic eye may still be in a normal state, which has the ability to image at the macular site, but due to the abnormal visual experience that has developed, the brain is not actively directing the visual stimulus, i.e. the ciliary muscles are not active or lazy to accommodate the lens. This reason results in the inability to treat amblyopia with the method of wearing glasses.
There are 6 current conventional methods for treating amblyopia: covering therapy, fine eyesight training, grating training, pricking training, eye muscle training and red filter therapy. Wherein: covering therapy is an ancient and effective treatment for amblyopia, which allows the amblyopia to undergo exercise by covering the active eyes. It is one of the simplest, most economical and most effective methods for treating amblyopia of children. However, the covering time needs to be scientifically adjusted, the covering for too long time causes the asthenopia, and due to the inherent pathological reasons, the adaptation to the imaging effect (unclear imaging) in the fatigue state is possibly caused, and the active adjustment is not performed any more. This causes the covering therapy to be passive and the physician is unable to take active treatment.
In summary, the following problems exist in the prior art: the covering therapy for treating amblyopia adopts passive therapy, and has low stimulation efficiency and poor treatment effect.
Disclosure of Invention
The invention provides an amblyopia treatment device for intelligently guiding visual stimulation, which aims to solve the problems of low stimulation efficiency and poor treatment effect of amblyopia treatment.
To this end, the present invention provides an amblyopia treatment device for intelligently guiding visual stimulation, comprising:
the first dimming film is arranged on a first lens of the glasses and used for adjusting the light transmission intensity of the first lens under the condition of electrifying;
the first bending membrane is arranged on a second lens of the glasses and used for adjusting the diopter of the second lens under the condition of electrification;
first control module, the setting is on the glasses with first membrane homonymy of adjusting luminance and the first membrane of adjusting luminance is connected to the electricity, and first control module includes: a first power supply and a first control circuit board;
the second control module sets up on the glasses with first flexible membrane homonymy and the first flexible membrane of electricity connection, and second control module includes: a second power supply and a second control circuit board.
Further, the first light adjusting film is arranged on the outer side of the first lens.
Further, the first flexure membrane is disposed inside the second lens.
Further, the first light adjusting film includes: two transparent conducting layers and be located and connect gradually between two transparent conducting layers: an ion storage layer, an electrolyte layer, and an electrochromic layer.
Further, the amblyopia treatment device for intelligently guiding visual stimulation further comprises: and the upper end and the lower end of the first dimming film are respectively connected between the positive electrode and the negative electrode of the first dimming film electrode.
Further, after voltage is applied to the first light modulation film electrode, ions stored in the ion storage layer are injected into lattice gaps of the electrochromic layer film through the electrolyte layer under the action of an electric field, and electrons in the electrochromic layer generate interband transition to absorb photons to cause color change.
Further, the first bending membrane includes: the device comprises a circular elastic membrane, two magnetic membrane rings arranged at intervals in the circular elastic membrane, and transparent filling liquid filled between the magnetic membrane rings and the circular elastic membrane;
two magnetic film rings are coaxial setting with circular elastic membrane, and solenoid has been put to the equipartition on two magnetic film rings, and first flexible membrane still includes: and the lead wires extend outwards from each magnetic film ring, are connected with the electromagnetic coils and are connected with a power supply of the second control module.
Furthermore, the magnetic film ring is made of polytetrafluoroethylene materials, the thickness of the magnetic film ring is 0.5mm, the ring width is 2-3 mm, and the inner diameter is 25-30 mm.
Further, the transparent filling liquid is ethylene glycol.
Further, the amblyopia treatment device for intelligently guiding visual stimulation further comprises:
the second light adjusting film is arranged on a second lens of the glasses and used for adjusting the light transmitting intensity of the second lens;
the second bending changing film is arranged on the first lens of the glasses and used for adjusting the diopter of the first lens;
the first control module is also electrically connected with a second variable curved membrane;
the second control module is also electrically connected with the second dimming film.
According to the invention, the varix film and the light modulation film are respectively applied to the inner side and the outer side of the lens, so that the effects of adjusting the diopter degree and the light intensity of the lens are realized, the brain is guided to adjust ciliary muscles and other related muscles, the dioptric effect of crystalline lenses is adjusted, the consciousness of the brain on abnormal vision is gradually improved, and amblyopia is treated. Has the beneficial effects that:
1. the invention customizes the stimulation frequency and the adjustment degree aiming at the amblyopia condition of a patient, guides the visual stimulation through the moderate refraction degree and the timely frequency change, leads the brain to actively adjust the muscles such as ciliary body and the like, and achieves the treatment aim; the treatment state is changed from passive state to active state, and the stimulation efficiency is improved.
2. The invention discloses a device for adjusting the focal length of a spectacle lens, and develops a bending film attached to the surface of the lens;
3. by utilizing an electrochromic principle, the device for adjusting the light intensity of the glasses lens is invented, and a light adjusting film attached to the surface of the lens is developed;
4. the structure of wearing the glasses is adopted, so that the treatment time is prolonged from less than 8 hours per day of the covering method to the whole time period of wearing the glasses.
Drawings
FIG. 1 is a schematic diagram of clear imaging of the human eye;
FIG. 2 is a schematic diagram of the imaging of amblyopia caused by refraction of a human eye;
fig. 3 is a schematic view of a primary view structure of an intelligent visual stimulation-guided amblyopia treatment device according to a first embodiment of the present invention, wherein a first light modulation film is disposed on a first lens of a pair of glasses, and a first curvature-changing film is disposed on a second lens of the pair of glasses;
FIG. 4 is a side view of the first lens of FIG. 3;
FIG. 5 is a side view of the second lens of FIG. 3;
fig. 6 is a schematic view of an internal structure of the first light adjusting film;
FIG. 7 is a schematic structural view in a front view direction of an internal structure of a first bending membrane;
FIG. 8 is a side view of the internal structure of the first bending membrane;
FIG. 9 is a schematic view of the first flex film before focusing;
FIG. 10 is a diagram illustrating a state after the first variable curvature film is focused;
FIG. 11 is a schematic view of the front view of an amblyopia treatment device for intelligently guiding visual stimulation according to a second embodiment of the present invention, wherein each lens has a light adjusting film and a curvature changing film;
fig. 12 is a schematic structural diagram of a second lens according to a second embodiment of the invention.
Detailed Description
In order to more clearly understand the technical features, objects, and effects of the present invention, the present invention will now be described with reference to the accompanying drawings.
Principle of method
The aim of the existing covering therapy is that after covering healthy eyes, weak eyes are forced to adjust the diopter of crystalline lens to obtain clear imaging. The brain develops a self-adjusting habit by continuously exercising ciliary muscles and neural sensitivity. The method has a problem that the brain has a desire to keep clear imaging at the early stage of covering and strengthening eyes, and the amblyopia eye is regulated to a certain degree. However, over time, the abnormal visual experience that amblyopic eyes have developed slowly reduces the willingness to adjust the brain. I.e. covering for a period of time, the amblyopic eye stops the therapeutic exercise. In this case, conditions such as reduction of light due to masking of healthy eyes may adversely reduce visual functions of amblyopic eyes, which may be a cause of insignificant or poor effects of masking of parts of cases.
It is clear that the critical period of willingness of the brain to maintain clear imaging is exploitedThe optimum time for the amblyopia eye exercise treatment is set as Tb. The duration is obtained by darkening the dimming film of the eye-care spectacle lens, and the darkening process simulates a covering process, so that the amblyopia eye can voluntarily adjust the lens diopter and the pupil size to obtain clear imaging. The dimming film can stimulate the brain and guide the visual stimulation. At TbIn the time quantum, become curved membrane work, carry out focus according to setting for the procedure and adjust, the parameter includes: focal length maintenance duration tlmAnd a focusing time period tla,Tb=tlm+tlaIt is usually designed according to the degree of amblyopia and the purpose of treatment. Focusing time period tlaTypically in the range of 100ms to 1000 ms. t is tla<At 400ms, the visual stimulation is sudden, namely imaging is suddenly blurred, the intensity of the visual stimulation is high, and discomfort such as dizziness and the like is easily caused due to too frequent visual stimulation. t is tla>At 1000ms, the visual stimulation is weak and the brain's will of regulation is difficult to trigger.
In addition, the guide frequency n needs to be designed specifically, namely the guide frequency of each visual activity period, and n/d and d are day, which means each day.
As shown in fig. 3, the amblyopia treatment device with intelligent guiding of visual stimuli according to the first embodiment of the present invention includes:
the first dimming film is arranged on a first lens of the glasses, the first lens is a right lens for example, and the first dimming film is used for adjusting the light transmission intensity of the first lens under the condition of electrifying;
the first bending membrane is arranged on a second lens of the glasses, and the second lens is a left lens for adjusting the diopter of the second lens under the condition of electrifying;
first control module, the setting is on the glasses with first membrane homonymy of adjusting luminance and the first membrane of adjusting luminance is connected to the electricity, for example, sets up on the peripheral frame of right lens, and first control module includes: a first power supply and a first control circuit board; for providing voltage and automatic control;
the second control module sets up on the glasses with first inflection membrane homonymy and the first inflection membrane of electricity connection, for example, sets up on the peripheral frame of left spectacle lens, and the second control module includes: a second power supply and a second control circuit board.
Here, left and right are opposite, if the first lens is set as a right eye lens, the second lens is a left eye lens, and if the first lens is set as a left eye lens, the second lens is a right eye lens. In this embodiment, a curvature changing film is provided on the lens for amblyopia, and a light adjusting film is provided on the lens for eye health.
By applying voltage or further adjusting voltage, the light adjusting film can uniformly adjust the light intensity of the light transmission and change from transparent to opaque so as to simulate covering treatment. By applying voltage or further adjusting voltage, the bending membrane can uniformly adjust diopter and change imaging focal length. Through proper refraction and timely frequency change, visual stimulation is guided, so that the brain actively adjusts muscles such as ciliary body and the like, and the treatment purpose is achieved.
Further, as shown in fig. 5, the first light adjusting film is provided on the outer side of the first lens (right eye lens) for easy masking and fabrication. The area of the first light adjusting film is equal to the area of the first lens or covers the main body part of the first lens, so that the covering function is realized.
Further, as shown in fig. 4, the first bending membrane is disposed inside the second lens, so as to adjust diopter and manufacture. As shown in fig. 11 and 12, in the case where there are a light adjusting film and a curvature changing film on each lens, the curvature changing film is provided on the inner side of the lens (near the eyeglasses), and the light adjusting film is provided on the outer side of the lens (far from the eyeglasses), so that the light adjusting film and the curvature changing film do not interfere with each other.
Further, as shown in fig. 6, the first light adjusting film includes: two transparent conducting layers and be located and connect gradually between two transparent conducting layers: an ion storage layer, an electrolyte layer, and an electrochromic layer.
Electrochromism refers to a phenomenon in which optical properties (reflectivity, transmittance, absorption, and the like) of a material undergo a stable and reversible color change under the action of an applied electric field, and is visually represented as a reversible change in color and transparency. Materials with electrochromic properties are referred to as electrochromic materials.
When no voltage is applied across the transparent conductive layer (for example, when a voltage is applied in the left-right direction in fig. 6, the top end is connected to the positive electrode and the negative electrode on the inner and outer sides, respectively, or the top end is connected to the positive electrode and the negative electrode on the upper and lower ends (the inner and outer sides, respectively) during the application), the entire light-adjusting film is colorless. After application of a voltage, lithium ions stored in the ion storage layer are injected into the electrochromic layer through the electrolyte layer under the action of an electric field (tungsten trioxide WO)3) In the lattice voids of the thin film, LiWO is formed3-xResult in being W6+Reduction to lower valent W5+Electrons from W6+To W5+The interband transition of (a) absorbs the photon and causes the color change. WO3The color change effect of the eye cream is dark blue, and the eye cream has a protective effect on eye health.
The transparent conductive layer is made of ITO (indium tin oxide) material. When the thickness is only hundreds of nanometers (less than 1 micron), the indium oxide has high transmittance and the tin oxide has strong conductive capability. Because the coating is very thin and the medium must be carried, the liquid crystal display usually uses ITO coated rear glass. The design selects low-resistance glass with the thickness of 0.4mm, and the glass with the thickness and the conductivity is generally used for the STN liquid crystal display and has high safety and reliability.
The light-adjusting membrane electrodes are positioned at two ends of the membrane and fixed near the upper edge and the lower edge of the glasses frame. One side of the light adjusting film is bonded to the eyeglass lens by OCA optical cement (film sticking method). The OCA is a special double-sided adhesive tape with optical transparency, is prepared by preparing an optical acrylic adhesive into a non-substrate, then respectively attaching a layer of release film to an upper bottom layer and a lower bottom layer, is a high-transparency double-sided adhesive tape without a substrate, and is commonly used for bonding mobile phones, touch screens and the like.
Voltage range applied to the light adjusting film: 0-3V, safety and reliability, low energy consumption, stepless adjustment of voltage, and uniform adjustment of light transmission intensity by the light adjusting film from transparency to opacity.
The area of the light adjusting film is cut and manufactured according to the size of the glasses lens of the patient glasses.
Further, the amblyopia treatment device for intelligently guiding visual stimulation further comprises: the first dimming membrane electrode, namely the electrode strip in fig. 3, is connected to a power supply of the control module, and includes a positive electrode and a negative electrode, which are respectively disposed on an upper edge and a lower edge of the first lens frame to achieve shape matching with the lens frame, and upper and lower ends of the first dimming membrane are respectively connected between the positive electrode and the negative electrode of the first dimming membrane electrode to achieve energization.
Further, after voltage is applied to the first light modulation film electrode, ions stored in the ion storage layer are injected into lattice gaps of the electrochromic layer film through the electrolyte layer under the action of an electric field, and electrons in the electrochromic layer generate interband transition to absorb photons to cause color change. Thus, the color of the light adjusting film and the lens can be changed by controlling the power supply or the voltage.
Further, as shown in fig. 7, 8, 9 and 10, the first variogram film includes: the device comprises a circular elastic membrane, two magnetic membrane rings arranged at intervals in the circular elastic membrane, and transparent filling liquid filled between the magnetic membrane rings and the circular elastic membrane; the bending membrane can uniformly adjust diopter and change the imaging focal length;
two magnetic film rings are coaxial setting with circular elastic membrane, and every magnetic film ring includes: the first bending membrane comprises a magnetic membrane ring base or a magnetic membrane ring body, wherein each magnetic membrane ring is provided with an electromagnetic coil, such as a thin film type electromagnetic coil, the electromagnetic coil surrounds the outer edge of the magnetic membrane ring base or the magnetic membrane ring body, and the first bending membrane further comprises: and a lead (also called a signal wire) extending outwards from each magnetic film ring, wherein the lead is connected with the electromagnetic coil and is connected with a power supply of the second control module. When the two magnetic film rings are not electrified, for example, they are parallelly arranged, and under the condition of electrification, the coils at two sides are mutually repelled, and the distance between two rings is defined according to the setting value of amblyopia treatment of human eye, and d0Increase to diAccordingly, the curvature of the inner side of the modified membrane becomes large (the radius of curvature becomes small, and R0 becomes Ri), and the entire diopter increases.
Furthermore, the magnetic film ring substrate or the magnetic film ring main body is made of polytetrafluoroethylene material, the thickness of the polytetrafluoroethylene material is 0.5mm, the ring width is 2-3 mm, the inner diameter is 25-30 mm, and the polytetrafluoroethylene material has elasticity, light transmittance and proper strength.
Further, the transparent filling liquid is ethylene glycol. Ethylene glycol, its optical properties are good. The freezing point is-11.5 ℃ and the boiling point is 197.4 ℃. The ethylene glycol viscosity is within 14-21 mPa.s under the condition of room temperature (20-30 ℃), and the ethylene glycol is suitable for normal activities of people. The liquid property of the glycol ensures better stability when the two magnetic film rings move relatively.
Control module
The control module comprises a power supply (such as a button battery) and a circuit board, and the circuit board is provided with a USB interface, so that the treatment program can be adjusted conveniently.
The main parameters and the adjusting effect of the control program are shown in the table 1:
TABLE 1 control procedure Main parameters
Figure BDA0003286100000000071
Further, as shown in fig. 11 and 12, the amblyopia treatment device for intelligently guiding visual stimulation according to the second embodiment of the present invention has a light adjusting film and a curvature changing film on each lens to adapt to the condition that both eyes are amblyopia;
the amblyopia treatment device for intelligently guiding visual stimulation further comprises:
the second light adjusting film is arranged on a second lens of the glasses and used for adjusting the light transmitting intensity of the second lens;
the second bending changing film is arranged on the first lens of the glasses and used for adjusting the diopter of the first lens;
the first control module is also electrically connected with a second variable curved membrane;
the second control module is also electrically connected with the second dimming film.
Wherein, the structure and the size of second membrane and first membrane of adjusting luminance all can be the same, and the structure and the size of second membrane and first membrane of becoming bent all can be the same, and the structure and the size of first control module and second control module all can be the same to preparation and use.
The working process of the invention is exemplified as follows:
(1) structural design:
the amblyopia treatment device capable of intelligently guiding visual stimulation has a structure in the form of glasses. Add amblyopia treatment components on the lens of the original glasses (if no, flat glasses can be used) of the children patient, namely: the device comprises a dimming film, a curvature changing film and a control module. The whole part is light in weight and does not cause discomfort in wearing.
(2) Working process
Taking a child patient with amblyopia in the left eye as an example, the left eye has 600 degrees of hyperopia, and the right eye is normal. Profile intelligence guides the application process of the visual stimulation apparatus.
Checking amblyopia
And performing various examinations such as conventional amblyopia degree. In addition, the reaction degree of the spectacle power is reduced under the existing vision condition, the power Cg under the condition that the stimulation reaction is generated but no obvious dizziness, nausea and the like is recorded, and the Cg is usually not more than the original power plus 100 degrees. This example tests the left eye's perception of hyperopia at 500 degrees.
Inquiring and recording the application eyesight duration and activity details of each stage of the infant patient, so as to conveniently make a targeted treatment program.
Second, intelligent guide program is compiled and glasses are debugged
The parameters within the bootstrap procedure (table 1) were determined one-to-one, including the modification of the post-treatment protocol.
Selecting proper light adjusting film and bending film. The curvature-variable film can adjust the concave degree to increase, so that the spectacles of the children patient can change from 600 degrees of far vision to 500 degrees. The light adjusting film is adhered to the outer sides of two lenses of the glasses worn by the sick children (the left light adjusting film does not work basically only for keeping the symmetry and the beauty of the appearance of the lenses), the curved film is used for adjusting the amblyopia, and the light adjusting film is used for adjusting the health of the eyes. The electrode wire is connected with a corresponding electrode of the control module, and the light adjusting film and the bending film adjust the transmittance and the diopter according to the program time.
Initiating program and stopping
The program can be started from the beginning of the visual work of the infant (waking up). The frequency of the adjustment by the light adjusting film was set to 12 times/d, and was about once per hour. When the light adjusting film is adjusted to be opaque, the amblyopia eye is subjected to preliminary stimulation, the myopic degree of the varix film is increased once every 12 minutes according to a design value (5 times/hour), the duration is 10 seconds, then the varix film recovers the non-refraction state, the recovery adjusting time of the amblyopic eye lens is not less than 2 seconds, and the 12 second time is the time for actively exercising the amblyopia eye.
Before the next exercise cycle begins, the light-adjusting film is restored to be transparent, and becomes opaque after 2 seconds, so that the brain is guided to enter a visual stimulation stage. The program then directs the above actions to be repeated.
If special activity content is met in daily life, the program can be paused, and the pause button can be pressed.
Before sleeping (or needing time), a stop button is arranged on the picture frame, and the program can be stopped until the next start.
Amblyopia eye examination and program modification
The treatment needs to be carried out once every month, and the guiding program is adjusted in time according to the vision improvement condition, such as increasing the adjustment frequency and the like. The modified program is implanted in the control module for the next stage of treatment.
According to the invention, the varix film and the light modulation film are respectively applied to the inner side and the outer side of the lens, so that the effects of adjusting the diopter degree and the light intensity of the lens are realized, the brain is guided to adjust ciliary muscles and other related muscles, the dioptric effect of crystalline lenses is adjusted, the consciousness of the brain on abnormal vision is gradually improved, and amblyopia is treated.
The above description is only an exemplary embodiment of the present invention, and is not intended to limit the scope of the present invention. In order that the components of the present invention may be combined without conflict, it is intended that all equivalent changes and modifications made by those skilled in the art without departing from the spirit and principles of the present invention shall fall within the protection scope of the present invention.

Claims (10)

1. An intelligent visual stimulus-directed amblyopia treatment apparatus, comprising:
the first dimming film is arranged on a first lens of the glasses and used for adjusting the light transmission intensity of the first lens under the condition of electrifying;
the first bending membrane is arranged on a second lens of the glasses and used for adjusting the diopter of the second lens under the condition of electrification;
first control module, the setting is on the glasses with first membrane homonymy of adjusting luminance and the first membrane of adjusting luminance is connected to the electricity, and first control module includes: a first power supply and a first control circuit board;
the second control module sets up on the glasses with first flexible membrane homonymy and the first flexible membrane of electricity connection, and second control module includes: a second power supply and a second control circuit board.
2. An amblyopia treatment device for intelligent guidance of visual stimuli according to claim 1, wherein the first light adjusting film is arranged outside the first lens.
3. An intelligent visual stimulus-directed amblyopia treatment device as claimed in claim 1, wherein the first inflection membrane is provided on the inner side of the second lens.
4. An amblyopia treatment device of intelligent guided visual stimulation according to claim 1, wherein said first light adjusting film comprises: two transparent conducting layers and be located and connect gradually between two transparent conducting layers: an ion storage layer, an electrolyte layer, and an electrochromic layer.
5. The intelligent guided visual stimulus amblyopia treatment apparatus of claim 4, wherein said intelligent guided visual stimulus amblyopia treatment apparatus further comprises: and the upper end and the lower end of the first dimming film are respectively connected between the positive electrode and the negative electrode of the first dimming film electrode.
6. The apparatus for treating amblyopia of claim 4, wherein after applying voltage to the first light modulation film electrode, the ions stored in the ion storage layer are injected into the lattice space of the electrochromic layer film through the electrolyte layer under the action of the electric field, and the electrons in the electrochromic layer undergo interband transition to absorb photons to cause discoloration.
7. An amblyopia treatment device of intelligent guided visual stimulation according to claim 1, wherein the first inflection membrane comprises: the device comprises a circular elastic membrane, two magnetic membrane rings arranged at intervals in the circular elastic membrane, and transparent filling liquid filled between the magnetic membrane rings and the circular elastic membrane;
two magnetic film rings are coaxial setting with circular elastic membrane, and solenoid has been put to the equipartition on two magnetic film rings, and first flexible membrane still includes: and the lead wires extend outwards from each magnetic film ring, are connected with the electromagnetic coils and are connected with a power supply of the second control module.
8. An intelligent visual stimulation-guided amblyopia treatment device as claimed in claim 1, wherein said magnetic film ring is made of polytetrafluoroethylene material, and has a thickness of 0.5mm, a ring width of 2-3 mm, and an inner diameter of 25-30 mm.
9. An intelligent visual stimulus-directed amblyopia treatment device as claimed in claim 1, wherein the transparent filler fluid is ethylene glycol.
10. The intelligent guided visual stimulus amblyopia treatment apparatus of claim 1, wherein said intelligent guided visual stimulus amblyopia treatment apparatus further comprises:
the second light adjusting film is arranged on a second lens of the glasses and used for adjusting the light transmitting intensity of the second lens;
the second bending changing film is arranged on the first lens of the glasses and used for adjusting the diopter of the first lens;
the first control module is also electrically connected with a second variable curved membrane;
the second control module is also electrically connected with the second dimming film.
CN202111147800.2A 2021-09-29 2021-09-29 Amblyopia treatment device capable of intelligently guiding visual stimulation Active CN113730089B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111147800.2A CN113730089B (en) 2021-09-29 2021-09-29 Amblyopia treatment device capable of intelligently guiding visual stimulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111147800.2A CN113730089B (en) 2021-09-29 2021-09-29 Amblyopia treatment device capable of intelligently guiding visual stimulation

Publications (2)

Publication Number Publication Date
CN113730089A true CN113730089A (en) 2021-12-03
CN113730089B CN113730089B (en) 2022-05-17

Family

ID=78741767

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111147800.2A Active CN113730089B (en) 2021-09-29 2021-09-29 Amblyopia treatment device capable of intelligently guiding visual stimulation

Country Status (1)

Country Link
CN (1) CN113730089B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2128875Y (en) * 1992-07-11 1993-03-31 浙江大学 Improved glasses for curing amblyopia of children
CN2294711Y (en) * 1997-03-27 1998-10-21 程康 Glasses for correcting amblyopia
US20050001980A1 (en) * 2003-07-04 2005-01-06 Spector Robert T. Method of and apparatus for diagnosing and treating amblyopic conditions in the human visual system
US20150219929A1 (en) * 2012-09-18 2015-08-06 Prof Joshua David SILVER Treatment of amblyopia
CN206532048U (en) * 2016-12-20 2017-09-29 山西瑞豪生物科技有限公司 A kind of eyeglass and the glasses for treating amblyopia
CN111240041A (en) * 2020-03-27 2020-06-05 清华大学深圳国际研究生院 Electromagnetic mechanical zoom glasses for preventing or delaying myopia

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2128875Y (en) * 1992-07-11 1993-03-31 浙江大学 Improved glasses for curing amblyopia of children
CN2294711Y (en) * 1997-03-27 1998-10-21 程康 Glasses for correcting amblyopia
US20050001980A1 (en) * 2003-07-04 2005-01-06 Spector Robert T. Method of and apparatus for diagnosing and treating amblyopic conditions in the human visual system
US20150219929A1 (en) * 2012-09-18 2015-08-06 Prof Joshua David SILVER Treatment of amblyopia
CN206532048U (en) * 2016-12-20 2017-09-29 山西瑞豪生物科技有限公司 A kind of eyeglass and the glasses for treating amblyopia
CN111240041A (en) * 2020-03-27 2020-06-05 清华大学深圳国际研究生院 Electromagnetic mechanical zoom glasses for preventing or delaying myopia

Also Published As

Publication number Publication date
CN113730089B (en) 2022-05-17

Similar Documents

Publication Publication Date Title
CN107219641B (en) Impulse positive lens design for myopia control, depth of focus extension and presbyopia correction
US11480798B2 (en) Light control devices and methods for regional variation of visual information and sampling
US10386646B1 (en) Light control devices and methods for regional variation of visual information and sampling
CN106054403B (en) Glasses with dynamic slight defocusing and zooming functions in emmetropic direction
CN114981713A (en) Contact lens for an eye
CN113730089B (en) Amblyopia treatment device capable of intelligently guiding visual stimulation
CN206532048U (en) A kind of eyeglass and the glasses for treating amblyopia
KR102122431B1 (en) Eye irritation apparatus and control method thereof
CN204246450U (en) A kind of Multifunctional shortsightedness health care therapeutical instrument
KR20110133968A (en) Glasses using micro electrical current
CN213130647U (en) Zoom lens type amblyopia suppression glasses
CN117814995A (en) Gentle electronic wind protection glasses for preventing and treating simple myopia and application thereof
ES1298738U (en) System of corrective lenses for visual defects caused by the abuse of short-distance vision (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant